The global pharmaceutical landscape is undergoing one of its most significant transformations in decades. Driven by an unprecedented surge in specialized biologics, the relentless growth of generic drug requirements, and an increasingly strict regulatory environment, drug manufacturers are forced to rethink their production floors. At the center of this evolution is the industrial machinery...